Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hohenberger

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumorsA J Wagner, H Kindler, H Gelderblom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimenM Streit, U Jaehde, S Stremetzne, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 5, 2014
Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study)S Bauer, P Rutkowski, P Hohenberger, et al.
Cancer Research|October 15, 1996
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumorsA S Lübbe, C Bergemann, H Riess, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year periodG Maschmeyer, F-L Bertschat, K T Moesta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2011
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcomaA Gronchi, B N Bui, S Bonvalot, et al.
Der Pathologe|August 17, 2010
[Molecular pathology of sarcomas. Update on the research group "Molecular Diagnosis of Sarcomas"]A V Rüsseler, B Brors, T Fischer, et al.
Gynecologic Oncology|May 22, 2016
Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapyI Ray-Coquard, E Rizzo, J Y Blay, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2013
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic studyH Gelderblom, J Y Blay, B M Seddon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2014
Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trialsA Le Cesne, M Ouali, M G Leahy, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumorsA J Wagner, H Kindler, H Gelderblom, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimenM Streit, U Jaehde, S Stremetzne, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 5, 2014
Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study)S Bauer, P Rutkowski, P Hohenberger, et al.
Cancer Research|October 15, 1996
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumorsA S Lübbe, C Bergemann, H Riess, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year periodG Maschmeyer, F-L Bertschat, K T Moesta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2011
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcomaA Gronchi, B N Bui, S Bonvalot, et al.
Der Pathologe|August 17, 2010
[Molecular pathology of sarcomas. Update on the research group "Molecular Diagnosis of Sarcomas"]A V Rüsseler, B Brors, T Fischer, et al.
Gynecologic Oncology|May 22, 2016
Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapyI Ray-Coquard, E Rizzo, J Y Blay, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2013
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic studyH Gelderblom, J Y Blay, B M Seddon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2014
Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trialsA Le Cesne, M Ouali, M G Leahy, et al.
Pageof 16